Abstract
Purpose
The present study aims to assess the incidence of microsatellite instability (MSI) and mutations in the PTEN and beta-catenin (CTNNB1) genes in endometrial carcinomas and to analyze the detected defects in these factors in relation to each other and to the clinico-pathological features of tumors.
Materials and methods
In a series of 56 endometrioid endometrial carcinomas, the status of MSI was determined using nine polymorphic markers, and mutations in all exons of the PTEN gene and in exon 3 of the CTNNB1 gene were evaluated by SSCP and sequencing methods.
Results
Microsatellite instability was found in 18 carcinomas (32.1%, MSI+); the remaining 38 tumors were microsatellite stable (MSI−). In 15 cases (26.8%), a loss of heterozygosity (LOH) at the studied microsatellite markers also occurred. In 29 carcinomas (51.8%), mutations were found in the PTEN gene and in nine tumors (16.1%) in the CTNNB1 gene. PTEN mutations occurred significantly more frequently in MSI+ than in MSI− tumors (77.8 vs. 39.5%, p = 0.007), but, except for one, none of them was attributable to MSI. In contrast, incidence of CTNNB1 mutations in MSI+ and MSI− tumors no significantly differed between themselves (16.7 vs. 15.8%, p = 0.760). Interestingly, mutations in the CTNNB1 gene most frequently coexisted with mutations in the PTEN gene (7/9, 77.8%). However, this finding requires future verification on a larger group of cases. The incidence of MSI and PTEN, but not CTNNB1 mutations, was significantly more common in poorly, than in well-to-moderately, differentiated tumors (G3 vs. G1 + G2; p = 0.042, 0.039 and 0.958, respectively).
Conclusion
We conclude that most frequently occurring mutations in the PTEN gene may be a key event for the tumorigenesis of endometrioid endometrial carcinomas, while coexistence or absence of microsatellite instability or mutations in the CTNNB1 gene may reflect the heterogeneity of molecular mechanisms contributing to the development of these tumors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baldinu P, Cossu A, Manca A, Satta M, Pisano M, Casula M, Dessole S, Pintus A, Tanda F, Palmieri G (2002) Microsatellite instability and mutation analysis of candidate genes in unselected Sardinian patients with endometrial carcinoma. Cancer 94:3157–3167
Bockman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10–17
Boland CR, Thibodean SN, Hamilton SR, Sidransky D, Eschleman JR, Burt RW, Meltzer SJ, Rodriguez- Bigas MA, Fodde R, Ranzani GN, Srivastava S (1998) A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257
Bullions LC, Levine AJ (1998) The role of beta-catenin in cell adhesion, signalling transduction, and cancer. Curr Opin Oncol 10:81–87
Bussaglia E, Del Rio E, Matias-Guiu X, Prat J (2000) PTEN mutations in endometrial carcinoma: a molecular and clinicopathologic analysis of 38 cases. Hum Pathol 31:312–317
Cohn DE, Basil JB, Venegoni AR, Mutch DG, Rader JS, Herzog TJ, GersellDJ, Goodfellow PJ (2000) Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability. Gynecol Oncol 79:101–106
Creasman WT (1989) FIGO stages:1988 revisions. Gynecol Oncol 35:125–127
Fiumicino S, Ercoli A, Ferrandina G, Hess P, Raspaglio G, Genuardi M, Rowella V, Bellacosa A, Cicchillitti L, Mancuso S, Bignami M, Scambia G (2001) Microsatellite instability is an independent indicator of recurrence in sporadic stage I–II endometrial adenocarcinoma. J Clin Oncol 19:1008–1014
Gurin ChC, Federici MG, Kang L, Boyd J (1999) Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res 59:462–466
Kong D, Suzuki A, Zou T-T, Sakurada A, Kemp LW (1997) PTEN is frequently mutated in primary endometrial carcinomas. Nat Genet 17:143–144
Konopka B, Paszko Z, Janiec-Jankowska A, Goluda M (2002) Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias. Cancer Lett 178:43–51
Konopka B, Janiec-Jankowska A, Paszko Z, Goluda M (2004) The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma. J Cancer Res Clin Oncol 130:114–121
Koul A, Willen R, Benhald P-O, Nilbert M, Borg A (2002) Distinct sets of gene alterations in endometrial carcinoma implicate alternate models of tumorigenesis. Cancer 94:2369–2379
Lawes DA, SenGupta S, Boulos PB (2003) The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Sur Oncol 29:201–212
Lax SF, Kendal B, Tashiro H, Slebas RJ, Ellenson LH (2000) The frequency of p53, K-ras mutation, and microsatellite instability differs in uterine endometrioid and serous carcinoma. Cancer 88:814–824
Lax SF (2004) Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular based classification. Virchows Arch 444:213–223
MacDonald N, Salvesen H, Ryan A, Iversen OE, Akslen L, Jacobs IJ (2000) Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas. Cancer Res 60:1750–1752
Machin P, Catacus L, Pons C, Munoz J, Matias-Guiu X, Prat J (2002) CTNNB1 mutations and beta-catenin expression in endometrial carcinomas. Hum Pathol 33:206–212
Markowitz S (2000) TGF-beta receptor and DNA repair genes, coupled targets in pathway of human colon carcinogenesis. Biochem Biophys Acta 1470:13–20
Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, Dale D, Holowaty E, Bapat B, Gallinger S, Redston M (1999) Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 59:3346–3351
Muresu R, Sini MC, Cossu A, Tore S, Baldinu P, Manca A, Pisano M, Loddo C, Dessole C, Pintus A, Tanda F, Palmieri G (2002) Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer. Eur J Cancer 38:1802–1809
Mutter GL, Lin M-Ch, Fitzerald JT, Kum JB, Baak JP, Lees JA, Weng L-P, Eng Ch (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92:924–931
Ohwada M, Suzuki M, Kohno T, Saga Y, Takei Y, Jobo T, Kuramoto H, Sato I (2002) Involvement of microsatellite instability in lymph node metastasis of endometrial carcinoma. Cancer Genet Cytogenet 132:152–155
Persad S, Troussard AA, McPhee TR (2001) Tumour suppressor PTEN inhibits accumulation of beta-catenin and T cell/lymphoid enhancer factor I-mediated transcriptional activator. J Cell Biol 153:1161–1174
Risinger JI, Hayes AK, Maxwell GL, Corney ME, Dodge RK, Barret JC, Berchuck A (1998) PTEN mutations in endometrial cancer are associated with favourable clinical and pathologic characteristics. Clin Cancer Res 4:3005–3010
Risinger JI, Maxwell GL, Chandramouli GV, Jazaeri A, Aprelikova O, Patterson T, Berchuck A, Barrett JC (2003) Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer. Cancer Res 63:6–11
Sakuragi N, Hirai A, Tada M, Yamada H, Yamamoto R, Fujimoto S, Moriuchi T (2001) Dominant-negative mutation of p53 tumor suppressor gene in endometrial carcinoma. Gynecol Oncol 83:485–490
Salvesen HB, Stefansson I, Kretzschmar EI, Gruber P, MacDonald N, Ryan A, Jacobs II, Akslen LA, Das S (2004) Significance of PTEN alterations in endometrial carcinoma: a population-base study of mutations, promoter methylation and PTEN protein expression. Int J Oncol 25:1615–1623
Sambrook J, Fritsh EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Sansal I, Sellers W (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22:2954–2963
Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ (1994) Histological typing of female genital tract tumors. In: WHO: International histological typing of tumors. Springer, New York, pp 14–31
Sherman ME (2000) Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13:295–308
Shin KH, Park YJ, Park JG (2001) PTEN gene mutations in colorectal cancers displaying microsatellite instability. Cancer Lett 174:189–194
Stambolic V (2002) PTEN: a new twist on beta-catenin? Trends Pharmacol Sci 23:104–106
Tamura M, Gu J, Takino T, Yamada KM, (1999) Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and P130 Cas. Cancer Res 59:442–449
Tashiro H, Isacson C, Levine R, Kurman RJ, Cho KR, Hedrick R (1997) p53 gene mutations are common in uterine serous carcinoma and occurs early in their pathogenesis. Am J Pathol 150:177–185
Tibiletti MG, Furlan D, Taborelli M Facco C, Riva C, Franchi M, Cossu A, Trubia M, Taramelli R, Capella C (1999) Microsatellite instability in endometrial cancer: relation to histological subtypes. Gynecol Oncol 73:247–252
Wang H, Douglas W, Lia M, Edelman W, Kucherlapati R, Podsypanina K, Parsons R, Ellenson LH (2002) DNA mismatch repair deficiency accelerates endometrial tumorigenesis in PTEN heterozygous mice. Am J Pathol 160:1481–1486
Wappenschmidt B, Wardelmann E, Gehrig A Schőndorf T, Maass N, Bonatz G, Gassel AM, Pietsch T, Mallman P, Weber BHF, Schmutzler K (2004) PTEN mutations do not cause nuclear β-catenin accumulation in endometrial carcinomas. Hum Pathol 35:1260–1265
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Konopka, B., Janiec-Jankowska, A., Czapczak, D. et al. Molecular genetic defects in endometrial carcinomas: microsatellite instability, PTEN and beta-catenin (CTNNB1) genes mutations. J Cancer Res Clin Oncol 133, 361–371 (2007). https://doi.org/10.1007/s00432-006-0179-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-006-0179-4